202 related articles for article (PubMed ID: 26493028)
21. Delineation of clinical course, outcomes, and prognostic factors in patients with T-cell prolymphocytic leukemia.
Rose A; Zhang L; Jain AG; Poovathukaran Babu A; Sokol L; Saeed H; Mo Q; Fan W; Zhang X
Am J Hematol; 2023 Jun; 98(6):913-921. PubMed ID: 36964941
[TBL] [Abstract][Full Text] [Related]
22. T-cell prolymphocytic leukaemia: antigen receptor gene rearrangement and a novel mode of MTCP1 B1 activation.
De Schouwer PJ; Dyer MJ; Brito-Babapulle VB; Matutes E; Catovsky D; Yuille MR
Br J Haematol; 2000 Sep; 110(4):831-8. PubMed ID: 11054065
[TBL] [Abstract][Full Text] [Related]
23. Epigenetic alteration contributes to the transcriptional reprogramming in T-cell prolymphocytic leukemia.
Tian S; Zhang H; Zhang P; Kalmbach M; Lee JH; Ordog T; Hampel PJ; Call TG; Witzig TE; Kay NE; Klee EW; Slager SL; Yan H; Ding W
Sci Rep; 2021 Apr; 11(1):8318. PubMed ID: 33859327
[TBL] [Abstract][Full Text] [Related]
24. Genetic characterization of B-cell prolymphocytic leukemia: a prognostic model involving MYC and TP53.
Chapiro E; Pramil E; Diop M; Roos-Weil D; Dillard C; Gabillaud C; Maloum K; Settegrana C; Baseggio L; Lesesve JF; Yon M; Jondreville L; Lesty C; Davi F; Le Garff-Tavernier M; Droin N; Dessen P; Algrin C; Leblond V; Gabarre J; Bouzy S; Eclache V; Gaillard B; Callet-Bauchu E; Muller M; Lefebvre C; Nadal N; Ittel A; Struski S; Collonge-Rame MA; Quilichini B; Fert-Ferrer S; Auger N; Radford-Weiss I; Wagner L; Scheinost S; Zenz T; Susin SA; Bernard OA; Nguyen-Khac F; ;
Blood; 2019 Nov; 134(21):1821-1831. PubMed ID: 31527074
[TBL] [Abstract][Full Text] [Related]
25. Reconstruction of rearranged T-cell receptor loci by whole genome and transcriptome sequencing gives insights into the initial steps of T-cell prolymphocytic leukemia.
Patil P; Cieslak A; Bernhart SH; Toprak UH; Wagener R; López C; Wiehle L; Bens S; Altmüller J; Franitza M; Scholz I; Jayne S; Ahearne MJ; Scheffold A; Jebaraj BMC; Schneider C; Costa D; Braun T; Schrader A; Campo E; Dyer MJS; Nürnberg P; Dürig J; Johansson P; Böttcher S; Schlesner M; Herling M; Stilgenbauer S; Macintyre E; Siebert R
Genes Chromosomes Cancer; 2020 Apr; 59(4):261-267. PubMed ID: 31677197
[TBL] [Abstract][Full Text] [Related]
26. Prolymphocytic Leukemia: New Insights in Diagnosis and in Treatment.
Collignon A; Wanquet A; Maitre E; Cornet E; Troussard X; Aurran-Schleinitz T
Curr Oncol Rep; 2017 Apr; 19(4):29. PubMed ID: 28324286
[TBL] [Abstract][Full Text] [Related]
27. Unusually indolent T-cell prolymphocytic leukemia associated with a complex karyotype: is this T-cell chronic lymphocytic leukemia?
Soma L; Cornfield DB; Prager D; Nowell P; Bagg A
Am J Hematol; 2002 Nov; 71(3):224-6. PubMed ID: 12410582
[TBL] [Abstract][Full Text] [Related]
28. Ataxia-telangiectasia and T-cell leukemias: no evidence for somatic ATM mutation in sporadic T-ALL or for hypermethylation of the ATM-NPAT/E14 bidirectional promoter in T-PLL.
Luo L; Lu FM; Hart S; Foroni L; Rabbani H; Hammarström L; Yuille MR; Catovsky D; Webster AD; Vorechovský I
Cancer Res; 1998 Jun; 58(11):2293-7. PubMed ID: 9622061
[TBL] [Abstract][Full Text] [Related]
29. T-Cell Prolymphocytic Leukemia: Diagnosis, Pathogenesis, and Treatment.
Gutierrez M; Bladek P; Goksu B; Murga-Zamalloa C; Bixby D; Wilcox R
Int J Mol Sci; 2023 Jul; 24(15):. PubMed ID: 37569479
[TBL] [Abstract][Full Text] [Related]
30. Short telomeres and high telomerase activity in T-cell prolymphocytic leukemia.
Röth A; Dürig J; Himmelreich H; Bug S; Siebert R; Dührsen U; Lansdorp PM; Baerlocher GM
Leukemia; 2007 Dec; 21(12):2456-62. PubMed ID: 17898784
[TBL] [Abstract][Full Text] [Related]
31. Recurrent loss, but lack of mutations, of the SMARCB1 tumor suppressor gene in T-cell prolymphocytic leukemia with TCL1A-TCRAD juxtaposition.
Bug S; Dürig J; Oyen F; Klein-Hitpass L; Martin-Subero JI; Harder L; Baudis M; Arnold N; Kordes U; Dührsen U; Schneppenheim R; Siebert R
Cancer Genet Cytogenet; 2009 Jul; 192(1):44-7. PubMed ID: 19480937
[TBL] [Abstract][Full Text] [Related]
32. Characteristics, outcomes, prognostic factors and treatment of patients with T-cell prolymphocytic leukemia (T-PLL).
Jain P; Aoki E; Keating M; Wierda WG; O'Brien S; Gonzalez GN; Ferrajoli A; Jain N; Thompson PA; Jabbour E; Kanagal-Shamanna R; Pierce S; Alousi A; Hosing C; Khouri I; Estrov Z; Cortes J; Kantarjian H; Ravandi F; Kadia TM
Ann Oncol; 2017 Jul; 28(7):1554-1559. PubMed ID: 28379307
[TBL] [Abstract][Full Text] [Related]
33. Somatic mutations of JAK1 and JAK3 in acute leukemias and solid cancers.
Jeong EG; Kim MS; Nam HK; Min CK; Lee S; Chung YJ; Yoo NJ; Lee SH
Clin Cancer Res; 2008 Jun; 14(12):3716-21. PubMed ID: 18559588
[TBL] [Abstract][Full Text] [Related]
34. Expression of S100 Protein in CD4-positive T-cell Lymphomas Is Often Associated With T-cell Prolymphocytic Leukemia.
Aggarwal N; Pongpruttipan T; Patel S; Bayerl MG; Alkan S; Nathwani B; Surti U; Kitahara S; Chinthammitr Y; Swerdlow SH
Am J Surg Pathol; 2015 Dec; 39(12):1679-87. PubMed ID: 26379148
[TBL] [Abstract][Full Text] [Related]
35. Long-Smoldering T-prolymphocytic Leukemia: A Case Report and a Review of the Literature.
Gjelberg HK; Helgeland L; Liseth K; Micci F; Sandnes M; Russnes HG; Reikvam H
Curr Oncol; 2023 Nov; 30(11):10007-10018. PubMed ID: 37999147
[TBL] [Abstract][Full Text] [Related]
36. TCL1A gene involvement in T-cell prolymphocytic leukemia in Japanese patients.
Yokohama A; Saitoh A; Nakahashi H; Mitsui T; Koiso H; Kim Y; Uchiumi H; Saitoh T; Handa H; Jimbo T; Murayama K; Sakura T; Murakami H; Karasawa M; Nojima Y; Tsukamoto N
Int J Hematol; 2012 Jan; 95(1):77-85. PubMed ID: 22189846
[TBL] [Abstract][Full Text] [Related]
37. Advances in the understanding and management of T-cell prolymphocytic leukemia.
Laribi K; Lemaire P; Sandrini J; Baugier de Materre A
Oncotarget; 2017 Nov; 8(61):104664-104686. PubMed ID: 29262669
[TBL] [Abstract][Full Text] [Related]
38. Haploinsufficiency of CDKN1B contributes to leukemogenesis in T-cell prolymphocytic leukemia.
Le Toriellec E; Despouy G; Pierron G; Gaye N; Joiner M; Bellanger D; Vincent-Salomon A; Stern MH
Blood; 2008 Feb; 111(4):2321-8. PubMed ID: 18073348
[TBL] [Abstract][Full Text] [Related]
39. Immunophenotypic characterization of T-cell prolymphocytic leukemia.
Chen X; Cherian S
Am J Clin Pathol; 2013 Nov; 140(5):727-35. PubMed ID: 24124154
[TBL] [Abstract][Full Text] [Related]
40. [Cerebriform variant type of T cell prolymphocytic leukemia: Report of one case].
Peña C; Valladares X; Soto C; Encina A; Marinov N; Undurraga MS; Cabrera ME
Rev Med Chil; 2016 Jan; 144(1):124-8. PubMed ID: 26998991
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
